Egypt's GASC buys 34,450 tonnes of soyoil in local tender - trade
GASC had been seeking at least 3,000 tonnes of local soyoil and 2,000 tonnes of local sunflower oil in the tender for Feb. 1-15 arrival
Reuters News - 26 Dec 2019
Alexandria Co for Pharmaceuticals & Chemical Industries (AXPH.CA)
Also known as: Alex Co. Pharma, Alexandria Pharmaceuticals
102.00 EGP -1.42-1.373%
Alex Co. Pharma Stock Price & Performance
Recommendation
-
Div Yield
9.747%
P/E (Last 12 Month)
4.456
Upside
-
Target Price (Mean)
-
Open
104.00 EGP
Previous Close
103.42 EGP
Turnover
112.40K EGP
EPS
23.209 EGP
Volume
1,085
Transactions
19
Market Cap
517.10M EGP
IPO Date
27-Feb-1995
Analyst Estimates
| EPS | Revenue | |
|---|---|---|
| Mean Estimate |  | |
| Smart Estimate | | |
| Predicted Surprise | | |
| Mean Chg % | | |
Starmine Models
StarMine provides a suite of proprietary alpha-generating analytics and models spanning sectors, regions, and markets.
| Bullish | |
|---|---|
| Value Momentum | |
| Intrinsic Valuation | |
| Relative Valuation | |
| Credit Risk - Smart Ratios | |
| Credit Risk- Text Mining | |
| Bearish | |
|---|---|
| Price Momentum | |
About Alexandria Co for Pharmaceuticals & Chemical Industries
Business Summary
Manufacture of generic drugs, dental cartridges, medicated adhesive tapes, plasters, surgical gloves and sterile gauze dressing,eye drops, vitamins and veterinary products.
Country of Incorporation
Ownership Type
Established In
1962
Primary Sector
Stock Listing
| ID | Stock Type | Currency | Exchange | Symbol |
|---|---|---|---|---|
| AXPH.CASE | Ordinary | EGP | Egypt SE | AXPH |
Contact details
Primary address
Alexandria Co for Pharmaceuticals & Chemical Industries BuildingGamila Abou Herid Road
Al Awayed Area
21511
Egypt
Alexandria
CONTACT
- Tel: +20 3-331-0224
- Tel: +20 3-331-2226
- Fax: +20 3-330-2221
- www.alexcopharma.net
Region
AlexandriaOwnership
Ownership
| Investor | Holding | No. of Shares | Last Update |
|---|---|---|---|
| | | |
| | | |
Holding Concentrations
| Investor | Holding | No. of Shares | Last Update |
|---|---|---|---|
| | | |
| | | |
Financials
Revenue
Net Income
Profit Margin
Total Assets
Total Liabilities
Debt to Assets
Operating
Investing
Financing
Executives
Dr Abla Youssef Abdullah
Managing Director
Mr Mohammed Khalifa
Information Technology Director
Dr Mohammed Ashraf
Head of Marketing
Board Members
Dr Abla Youssef Abdullah
Chairperson and director representing Drug Holding Company
Dr Mohammed Hasan Suleiman Rabih
Director
Mr Saifuddine Ahmad Abdulmoati
Director
Company information provided by © 2020 Thomson Reuters
Thomson Reuters research team update company information from primary sources (company annual reports, press releases, company websites, corporate briefings, official statements/interviews) and reliable secondary sources (stock markets, reliable third party publications).
Morning Briefing
Thursday Outlook: World stocks pause at record peak as markets assess U.S.-China deal
Dollar softens, gold steadies and oil prices rise after "phase 1" deal inked
Read MoreStock Market Data
Powered By Knowledge Direct